REG - Spire Healthcare Grp - Director/PDMR Shareholding

Spire HealthcareAnnouncement

18/03/2026 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260318:nRSR1941Xa&default-theme=true

RNS Number : 1941X  Spire Healthcare Group PLC  18 March 2026

Spire Healthcare Group plc (the Company)

Notification of Transactions of Persons Discharging Managerial
Responsibilities

 

18 March 2026

 

Grant of Long Term Incentive Plan (LTIP) awards

The Company announces that, on 17 March 2026, performance share awards were
granted over the Company's ordinary shares in the form of nil cost options to
the following Executive Directors of the Company, under the rules of the
Company's Long Term Incentive Plan.

 

Executive Director                Maximum number of shares
under award

Justin Ash                               736,733

Harbant Samra                       451,653

 

The number of shares set out above represents 200% of current base salary. It
is the maximum number which may vest under the LTIP awards following the end
of the performance period (31 December 2028).  The shareholder-approved
Remuneration Policy permits awards of up to 200% of base salary for Executive
Directors.

 

The actual number of shares which vest will depend on the extent to which the
relevant performance conditions have been satisfied.

 

Given the current evaluation of actions to drive shareholder value, the
Remuneration Committee is taking further time to carefully consider and
determine the LTIP performance conditions and targets to ensure they are fully
aligned to the Company's forward-looking strategy. Once finalised, the 2026
LTIP performance conditions and targets will be published on the Company's
website, and they will be disclosed in the 2026 Directors' Remuneration
Report.

 

The share price used to determine the number of shares under the LTIP Awards
was 185.08 pence, being the average of the mid-market closing share price over
the five trading days ending on 16 March 2026.

 

 

Notes:

 

1)   For both Executive Directors the 2026 LTIP awards described above will
also be subject to a further two-year holding period following the vesting
date.

2)   The actual number of shares which vest under the LTIP awards will
depend on the extent to which the relevant performance conditions are
satisfied in due course.

Name of contact and telephone number for queries:

Mantraraj Budhdev

Group General Counsel, Chief People Officer and Company Secretary

Spire Healthcare Group plc

Tel: 07787 283848

 

 

 

 

Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Justin Ash

 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Long Term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
                                                                  Nil                                       736,733

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2026-03-17
 f)  Place of the transaction                                     Outside of trading venue

 

 a)  Name                                                         Harbant Samra

 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer

 b)  Initial notification /Amendment                              Initial notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Spire Healthcare Group plc

 b)  LEI                                                          213800IBJPW3SE2RA350

 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

     Identification code

                                                                  GB00BNLPYF73
 b)  Nature of the transaction                                    Grant of performance share awards under the Company's Long Term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)                                  Volume(s)
                                                                  Nil                                       451,653

 d)  Aggregated information                                       As above

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      2026-03-17
 f)  Place of the transaction                                     Outside of trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBUGDXLDBDGLI



            Copyright 2019 Regulatory News Service, all rights reserved